Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8607811rdf:typepubmed:Citationlld:pubmed
pubmed-article:8607811lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C1537647lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C0025723lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:8607811lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:8607811pubmed:issue3lld:pubmed
pubmed-article:8607811pubmed:dateCreated1996-5-20lld:pubmed
pubmed-article:8607811pubmed:abstractTextThe DNA methylation status of the 5'-regulatory region of human tumor necrosis factor-alpha (TNF-alpha) gene was examined using two human monocytic cell lines representing different differentiation stages: one cell line, THP-1, represents the most differentiated macrophage-like phenotypes and the other, HL-60, represents a least differentiated phenotype. Two restriction enzymes were used to detect methylated sites in the 5'-regulatory region of the TNF-alpha gene. The restriction enzyme Msp I, which recognizes both CCGG (unmethylated) and C(me)CGG (methylated) sequences, whereas Hpa II recognizes only the unmethylated CCGG sequence. Two Msp I sites located at -600 and +200 nucleotides, respectively, from the transcriptional initiation site were unmethylated in DNA from the THP-1, whereas these sites were methylated in the one from the HL-60. Treating the HL-60 cells with 1,25-vitamin D3, ( 1,25-(OH)2D3), which is known to induce monocytic cell differentiation, induce demethylation of the sites, suggesting the methylation status was correlated with the differentiation stages of monocytes.lld:pubmed
pubmed-article:8607811pubmed:languageenglld:pubmed
pubmed-article:8607811pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8607811pubmed:citationSubsetIMlld:pubmed
pubmed-article:8607811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8607811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8607811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8607811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8607811pubmed:statusMEDLINElld:pubmed
pubmed-article:8607811pubmed:monthMarlld:pubmed
pubmed-article:8607811pubmed:issn0006-291Xlld:pubmed
pubmed-article:8607811pubmed:authorpubmed-author:TakeoYYlld:pubmed
pubmed-article:8607811pubmed:authorpubmed-author:ToyodaHHlld:pubmed
pubmed-article:8607811pubmed:authorpubmed-author:FernandezDDlld:pubmed
pubmed-article:8607811pubmed:authorpubmed-author:RedfordAAlld:pubmed
pubmed-article:8607811pubmed:issnTypePrintlld:pubmed
pubmed-article:8607811pubmed:day27lld:pubmed
pubmed-article:8607811pubmed:volume220lld:pubmed
pubmed-article:8607811pubmed:ownerNLMlld:pubmed
pubmed-article:8607811pubmed:authorsCompleteYlld:pubmed
pubmed-article:8607811pubmed:pagination606-12lld:pubmed
pubmed-article:8607811pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:meshHeadingpubmed-meshheading:8607811-...lld:pubmed
pubmed-article:8607811pubmed:year1996lld:pubmed
pubmed-article:8607811pubmed:articleTitleMethylation status of 5'-regulatory region of tumor necrosis factor alpha gene correlates with differentiation stages of monocytes.lld:pubmed
pubmed-article:8607811pubmed:affiliationDepartment of Medicine, Ceders-Sinai Medical Center, UCLA School of Medicine, California 90048, USA.lld:pubmed
pubmed-article:8607811pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8607811pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8607811pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8607811lld:pubmed